Krystal Biotech
KRYS
KRYS
154 hedge funds and large institutions have $1.62B invested in Krystal Biotech in 2022 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 62 increasing their positions, 50 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.06% more ownership
Funds ownership: 81.12% → 81.18% (+0.06%)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
73% less call options, than puts
Call options by funds: $5.68M | Put options by funds: $21.4M
Holders
154
Holding in Top 10
5
Calls
$5.68M
Puts
$21.4M
Top Buyers
| 1 | +$10.7M | |
| 2 | +$10.6M | |
| 3 | +$7.29M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$5.23M |
| 5 |
NIP
Nicholas Investment Partners
Rancho Santa Fe,
California
|
+$3.57M |
Top Sellers
| 1 | -$55.6M | |
| 2 | -$9.46M | |
| 3 | -$7.92M | |
| 4 |
PAMS
Pictet Asset Management (Switzerland)
Geneva 73,
Switzerland
|
-$7.78M |
| 5 |
Nuveen Asset Management
Chicago,
Illinois
|
-$2.21M |